Abstract:AbstractPurposeTo explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS).MethodsA total of 634 consecutive patients diagnosed with MDS at The First Affiliated Hospital, Zhejiang University School of Medicine from June 2008 to May 2018 were retrospectively included in this study. All patients had evaluable cytogenetic analysis, and 425 patients had MDS‐related mutations sequencing.Results38.6% of patients displayed abnormal karyotypes. The most common cytogenetic abnormality was +8 (31%). Sole +8 was related to female (p = 0.002), hemoglobin >10 g/dL (p = 0.03), and <60 years old (p = 0.046). TP53 mutations were associated with complex karyotype (CK) (p < 0.001). DNMT3A mutations correlated with ‐Y (p = 0.01) whereas NRAS mutations correlated with 20q‐ (p = 0.04). The overall survival (OS) was significantly inferior in patients with +8 compared with those with normal karyotype (NK) (p = 0.003). However, the OS of sole +8 and +8 with one additional karyotypic abnormality was not different from NK (p = 0.16), but +8 with two or more abnormalities had a significantly shorter OS than +8 and +8 with one additional karyotypic abnormality (p = 0.02). In multivariable analysis, ≥60 years old, marrow blasts ≥5% and TP53 mutations were independent predictors for poor OS (p < 0.05), whereas SF3B1 mutations indicated better prognosis. Male IDH1 and IDH2 mutations and marrow blasts ≥5% were independent risk factors for worse leukemia free survival (LFS) (p < 0.05).ConclusionIn this population of Chinese patients, trisomy 8 is the most common karyotypic abnormality. Patients with +8 showed a poorer OS compared with patients with NK. Sole +8 and +8 with one additional karyotypic abnormality had similar OS with NK, whereas +8 with two or more abnormalities had a significantly shorter OS. DNMT3A mutations correlated with ‐Y and NRAS mutations correlated with 20q‐. TP53 mutations were associated with CK and had a poor OS. SF3B1 mutations indicated a favorable OS. IDH1 and IDH2 mutations independently indicated inferior LFS.

Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study

Association of the recurrence and canceration rate of vocal leukoplakia with interleukin-10 promoter variants over a 2-year period.

The Association Between Rs2910164 G>C Polymorphism in Pre-Microrna-146a and Laryngeal Cancer in Jiangsu Han Population

The Role of Keratin-8 and Keratin-18 Polymorphisms and Protein Levels in the Occurrence and Progression of Vocal Leukoplakia

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Correlation between hMLH1-93G/A gene polymorphism and colorectal cancer

P57(Kip2) Expression is Related to Carcinogenesis and Tumor Progression in Laryngeal Tissues

Association of MDM2 Promoter T309G Polymorphism with Oral Cancer Risk: A Meta-Analysis of 3,536 Subjects

Genetic polymorphisms and protein levels in vocal fold leukoplakia: a systematic review

Significance of Cytokeratin-1 Single-Nucleotide Polymorphism and Protein Level in Susceptibility to Vocal Leukoplakia and Laryngeal Squamous Cell Carcinoma

Analysis of prognostic factors for vocal fold leukoplakia based on 344 cases at a two-year follow up

The Variation of Peripheral Inflammatory Markers in Vocal Leukoplakia before and after Recurrence and Canceration

Mdm2 Promoter Snp309 Is Associated With Risk Of Occurrence And Advanced Lymph Node Metastasis Of Nasopharyngeal Carcinoma In Chinese Population

On Prognosis of Recurrence and Canceration After Mucosal Exfoliation for Vocal Cord Leukoplakia

Risk of MDM2 SNP309 Alone or in Combination with the P53 Codon 72 Polymorphism in Acute Myeloid Leukemia.

Association of Interleukin-10 Promoter Polymorphisms and Corresponding Plasma Levels with Susceptibility to Laryngeal Squamous Cell Carcinoma

[Clinical analyses of 263 patients with laryngeal leukoplakia]

A Genetic Polymorphism In Pre-Mir-27a Confers Clinical Outcome Of Non-Small Cell Lung Cancer In A Chinese Population

Association of P53 and MDM2 Polymorphisms with Risk of Human Papillomavirus (Hpv)-Related Esophageal Squamous Cell Carcinoma (ESCC).

MDM2 Promoter SNP309 is Associated with an Increased Susceptibility to Chronic Lymphocytic Leukemia and Correlates with MDM2 Mrna Expression in Chinese Patients with CLL

Treatment experience with and clinicopathological analysis of vocal fold leukoplakia per appearance classification guidance: a cohort of 1442 patients